OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Interim analysis from a phase 2 randomized trial of EuCorVac-19: a recombinant protein SARS-CoV-2 RBD nanoliposome vaccine
Jonathan F. Lovell, Yeong Ok Baik, Seuk Keun Choi, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 25
Jonathan F. Lovell, Yeong Ok Baik, Seuk Keun Choi, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 25
Showing 25 citing articles:
Long-acting vaccine delivery systems
Pavan Walvekar, Pradeep Kumar, Yahya E. Choonara
Advanced Drug Delivery Reviews (2023) Vol. 198, pp. 114897-114897
Closed Access | Times Cited: 21
Pavan Walvekar, Pradeep Kumar, Yahya E. Choonara
Advanced Drug Delivery Reviews (2023) Vol. 198, pp. 114897-114897
Closed Access | Times Cited: 21
Advances in SARS-CoV-2 receptor-binding domain-based COVID-19 vaccines
Xiao‐Qing Guan, Yang Yang, Lanying Du
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 422-439
Open Access | Times Cited: 18
Xiao‐Qing Guan, Yang Yang, Lanying Du
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 422-439
Open Access | Times Cited: 18
Adjuvanted nanoliposomes displaying six hemagglutinins and neuraminidases as an influenza virus vaccine
Zachary R. Sia, Jayishnu Roy, Wei‐Chiao Huang, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 3, pp. 101433-101433
Open Access | Times Cited: 6
Zachary R. Sia, Jayishnu Roy, Wei‐Chiao Huang, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 3, pp. 101433-101433
Open Access | Times Cited: 6
COVID-19 vaccines: A comprehensive review of safety and efficacy
Zhipeng Yan, Ming Yang, Ching‐Lung Lai
Elsevier eBooks (2025), pp. 685-777
Closed Access
Zhipeng Yan, Ming Yang, Ching‐Lung Lai
Elsevier eBooks (2025), pp. 685-777
Closed Access
Iterative selection of lipid nanoparticle vaccine adjuvants for rapid elicitation of tumoricidal CD8⁺ T cells
Yuan Luo, Shiqi Zhou, Yiting Song, et al.
Bioactive Materials (2025) Vol. 48, pp. 189-199
Closed Access
Yuan Luo, Shiqi Zhou, Yiting Song, et al.
Bioactive Materials (2025) Vol. 48, pp. 189-199
Closed Access
50-Fold Adjuvant and 20-Fold Antigen Vaccine Dose Sparing from Nanoliposome Display of a Stabilized Malarial Protein Antigen
Yiting Song, Wei‐Chiao Huang, Danton Ivanochko, et al.
ACS Nano (2025)
Closed Access
Yiting Song, Wei‐Chiao Huang, Danton Ivanochko, et al.
ACS Nano (2025)
Closed Access
Vaccine approaches for antigen capture by liposomes
Shiqi Zhou, Yuan Luo, Jonathan F. Lovell
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 1022-1040
Open Access | Times Cited: 14
Shiqi Zhou, Yuan Luo, Jonathan F. Lovell
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 1022-1040
Open Access | Times Cited: 14
Enhanced mucosal immune responses and reduced viral load in the respiratory tract of ferrets to intranasal lipid nanoparticle-based SARS-CoV-2 proteins and mRNA vaccines
Patricia A. Boley, Carolyn M. Lee, Jennifer Schrock, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 12
Patricia A. Boley, Carolyn M. Lee, Jennifer Schrock, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 12
One-year antibody durability induced by EuCorVac-19, a liposome-displayed COVID-19 receptor binding domain subunit vaccine, in healthy Korean subjects
Jonathan F. Lovell, Kazutoyo Miura, Yeong Ok Baik, et al.
International Journal of Infectious Diseases (2023) Vol. 138, pp. 73-80
Open Access | Times Cited: 11
Jonathan F. Lovell, Kazutoyo Miura, Yeong Ok Baik, et al.
International Journal of Infectious Diseases (2023) Vol. 138, pp. 73-80
Open Access | Times Cited: 11
Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster
Terry Nolan, Georgia Deliyannis, Maryanne Griffith, et al.
EBioMedicine (2023) Vol. 98, pp. 104878-104878
Open Access | Times Cited: 10
Terry Nolan, Georgia Deliyannis, Maryanne Griffith, et al.
EBioMedicine (2023) Vol. 98, pp. 104878-104878
Open Access | Times Cited: 10
CoPoP liposomes displaying stabilized clade C HIV-1 Env elicit tier 2 multiclade neutralization in rabbits
Annemart Koornneef, Kanika Vanshylla, Gijs Hardenberg, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Annemart Koornneef, Kanika Vanshylla, Gijs Hardenberg, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Interim safety and immunogenicity analysis of the EuCorVac‐19 COVID‐19 vaccine in a Phase 3 randomized, observer‐blind, immunobridging trial in the Philippines
Jonathan F. Lovell, Kazutoyo Miura, Yeong Ok Baik, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 9
Closed Access | Times Cited: 3
Jonathan F. Lovell, Kazutoyo Miura, Yeong Ok Baik, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 9
Closed Access | Times Cited: 3
Hybrid response to SARS-CoV-2 and Neisseria meningitidis C after an OMV-adjuvanted immunization in mice and their offspring
Amanda Izeli Portilho, Hernan Hermes Monteiro da Costa, Marcia Grando Guereschi, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 2
Amanda Izeli Portilho, Hernan Hermes Monteiro da Costa, Marcia Grando Guereschi, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 2
Liposomal Fba and Met6 peptide vaccination protects mice from disseminated candidiasis
Wei‐Chiao Huang, Karen Eberle, Jonothan A. Rosario-Colon, et al.
mSphere (2024) Vol. 9, Iss. 7
Open Access | Times Cited: 2
Wei‐Chiao Huang, Karen Eberle, Jonothan A. Rosario-Colon, et al.
mSphere (2024) Vol. 9, Iss. 7
Open Access | Times Cited: 2
Engineering Escherichia coli for constitutive production of monophosphoryl lipid A vaccine adjuvant
Hyunjung Jin, Yuhyun Ji, Jinsu An, et al.
Biotechnology and Bioengineering (2024) Vol. 121, Iss. 3, pp. 1144-1162
Closed Access | Times Cited: 1
Hyunjung Jin, Yuhyun Ji, Jinsu An, et al.
Biotechnology and Bioengineering (2024) Vol. 121, Iss. 3, pp. 1144-1162
Closed Access | Times Cited: 1
Identification of Enhanced Vaccine Mimotopes for the p15E Murine Cancer Antigen
Shiqi Zhou, Yiting Song, Yuan Luo, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 4, pp. 958-969
Open Access | Times Cited: 1
Shiqi Zhou, Yiting Song, Yuan Luo, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 4, pp. 958-969
Open Access | Times Cited: 1
Extraordinary Titer and Broad Anti-SARS-CoV-2 Neutralization Induced by Stabilized RBD Nanoparticles from Strain BA.5
Zhantong Wang, Baoshan Zhang, Li Ou, et al.
Vaccines (2023) Vol. 12, Iss. 1, pp. 37-37
Open Access | Times Cited: 4
Zhantong Wang, Baoshan Zhang, Li Ou, et al.
Vaccines (2023) Vol. 12, Iss. 1, pp. 37-37
Open Access | Times Cited: 4
Nanotechnology-Based Vaccines
Mohamed Hussein, Madiha Mumtaz, Iqra Nasir, et al.
Biology Medicine & Natural Product Chemistry (2023) Vol. 12, Iss. 1, pp. 343-361
Open Access | Times Cited: 3
Mohamed Hussein, Madiha Mumtaz, Iqra Nasir, et al.
Biology Medicine & Natural Product Chemistry (2023) Vol. 12, Iss. 1, pp. 343-361
Open Access | Times Cited: 3
SARS‐CoV‐2 Protein Nanoparticle Vaccines Formed In Situ From Lyophilized Lipids
Yang Jiao, Wei‐Chiao Huang, Kevin Chiem, et al.
Small (2023) Vol. 20, Iss. 9
Open Access | Times Cited: 3
Yang Jiao, Wei‐Chiao Huang, Kevin Chiem, et al.
Small (2023) Vol. 20, Iss. 9
Open Access | Times Cited: 3
Circularized Nanodiscs for Multivalent Mosaic Display of SARS-CoV-2 Spike Protein Antigens
Moustafa T. Mabrouk, Asmaa A. Zidan, Nihal Aly, et al.
Vaccines (2023) Vol. 11, Iss. 11, pp. 1655-1655
Open Access | Times Cited: 3
Moustafa T. Mabrouk, Asmaa A. Zidan, Nihal Aly, et al.
Vaccines (2023) Vol. 11, Iss. 11, pp. 1655-1655
Open Access | Times Cited: 3
Efficient capture of recombinant SARS-CoV-2 receptor-binding domain (RBD) with citrate-coated magnetic iron oxide nanoparticles
David A. González‐Martínez, Gustavo González Ruíz, Cesar Escalante-Bermúdez, et al.
Nanoscale (2023) Vol. 15, Iss. 17, pp. 7854-7869
Closed Access | Times Cited: 2
David A. González‐Martínez, Gustavo González Ruíz, Cesar Escalante-Bermúdez, et al.
Nanoscale (2023) Vol. 15, Iss. 17, pp. 7854-7869
Closed Access | Times Cited: 2
Displaying alphavirus physicochemical consensus antigens on immunogenic liposomes enhances antibody elicitation in mice
Wei‐Chiao Huang, Wendy S. Baker, Jonathan F. Lovell, et al.
Virology (2024) Vol. 597, pp. 110152-110152
Closed Access
Wei‐Chiao Huang, Wendy S. Baker, Jonathan F. Lovell, et al.
Virology (2024) Vol. 597, pp. 110152-110152
Closed Access
A pentavalent peptide vaccine elicits Aβ and tau antibodies with prophylactic activity in an Alzheimer’s disease mouse model
Yiting Song, Chun‐Ling Dai, Mitsuru Shinohara, et al.
Brain Behavior and Immunity (2024) Vol. 122, pp. 185-201
Closed Access
Yiting Song, Chun‐Ling Dai, Mitsuru Shinohara, et al.
Brain Behavior and Immunity (2024) Vol. 122, pp. 185-201
Closed Access
Multivalent administration of dengue E dimers on liposomes elicits type-specific neutralizing responses without immune interference
Thanh T.N. Phan, Matthew G. Hvasta, Devina Thiono, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Thanh T.N. Phan, Matthew G. Hvasta, Devina Thiono, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Human vaccines & immunotherapeutics: News November 2022
Ronald J. Ellis, Adam Weiss
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 7
Open Access
Ronald J. Ellis, Adam Weiss
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 7
Open Access
